No dose-response relationship of clarithromycin utilization on cardiovascular outcomes in patients with stable coronary heart disease: Analysis of Taiwan’s national health insurance claims data

BACKGROUND: Clarithromycin is widely used to treat various bacterial infections and has been reported to have potential cardiovascular risk. However, it is uncertain whether this association was dose dependent and confounded by indication bias in patients with stable coronary heart disease (CHD). ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Ben-Hui, Chen, Yen-Chun, Li, Yi-Da, Chiou, Wen-Yen, Chen, Yi-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645004/
https://www.ncbi.nlm.nih.gov/pubmed/36386302
http://dx.doi.org/10.3389/fcvm.2022.1018194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645004/
https://www.ncbi.nlm.nih.gov/pubmed/36386302
http://dx.doi.org/10.3389/fcvm.2022.1018194

Ejemplares similares